주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-26 16:52 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
All articles
목록
(
총 :
239 )
기사목록 보기 형태
제목형
요약형
포토형
Bridge Biotherapeutics passes preliminary review for Kosdaq listing
Jeong Sae-im
2019.10.25 15:01
KangStem Biotech fails in phase-3 study on atopic dermatitis drug
Jeong Sae-im
2019.10.25 11:15
Value assessment on anticancer drugs hotly discussed
Jeong Sae-im
2019.10.24 12:04
PharmAbcine sets up US unit to develop anticancer drug
Jeong Sae-im
2019.10.23 15:32
‘Oral drugs as effective as inhalers for elderly with asthma’
Jeong Sae-im
2019.10.22 15:29
Dong-A ST leaves KPBMA to ‘repent of illegal rebate’
Jeong Sae-im
2019.10.21 16:40
Drug firms’ Q3 earnings to be fairly good
Jeong Sae-im
2019.10.21 11:46
Medytox exported ₩3.3 billion worth of unqualified BTX
Jeong Sae-im
2019.10.18 15:19
US sales of Remicade drop due to biosimilar’s rise
Jeong Sae-im
2019.10.17 13:08
[Exclusive] Samsung admits it failed to develop Rituxan biosimilar
Jeong Sae-im
2019.10.16 13:05
Kolon Life Science shares surge after TissueGene’s survival
Jeong Sae-im
2019.10.14 15:10
HLB merges with Elevar to own rivoceranib rights
Jeong Sae-im
2019.10.14 14:31
처음
이전
이전
이전
11
12
13
14
15
16
17
18
19
20
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기